Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Huys

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
ESC Heart Failure|June 10, 2024
Heart failure patients' perspectives on treatment outcomes and unmet medical needs: A qualitative preference studyAlice Vanneste, Liese Barbier, Ramses Missotten, et al.
Frontiers in Pharmacology|May 7, 2026
International practices, barriers, and enablers for patient and public involvement in pricing and reimbursement decision-making: a mixed-methods studyAlice Vanneste, Morgane Deknudt, Elise Schoefs, et al.
Biomed Research International|May 29, 2014
Taking bacteriophage therapy seriously: a moral argumentGilbert Verbeken, Isabelle Huys, Jean-Paul Pirnay, et al.
Frontiers in Medicine|October 27, 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and PracticeRosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, et al.
Digital Health|July 5, 2022
Co-creation with research participants to inform the design of electronic informed consentEvelien De Sutter, David Geerts, Pascal Borry, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 2, 2021
Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique surveyEline van Overbeeke, Brett Hauber, Sissel Michelsen, et al.
Cell and Tissue Banking|September 21, 2013
Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systemsJean-Paul Pirnay, Alain Vanderkelen, Daniel De Vos, et al.
Research Involvement and Engagement|April 7, 2023
Patients as research partners in preference studies: learnings from IMI-PREFERMeredith Y Smith, Rosanne Janssens, A Cecilia Jimenez-Moreno, et al.
Frontiers in Medicine|October 14, 2022
Rethinking informed consent in the time of COVID-19: An exploratory surveyEvelien De Sutter, Teodora Lalova-Spinks, Pascal Borry, et al.
BMC Medical Informatics and Decision Making|November 18, 2022
Using provocative design to foster electronic informed consent innovationEvelien De Sutter, Stef Verreydt, Koen Yskout, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
ESC Heart Failure|June 10, 2024
Heart failure patients' perspectives on treatment outcomes and unmet medical needs: A qualitative preference studyAlice Vanneste, Liese Barbier, Ramses Missotten, et al.
Frontiers in Pharmacology|May 7, 2026
International practices, barriers, and enablers for patient and public involvement in pricing and reimbursement decision-making: a mixed-methods studyAlice Vanneste, Morgane Deknudt, Elise Schoefs, et al.
Biomed Research International|May 29, 2014
Taking bacteriophage therapy seriously: a moral argumentGilbert Verbeken, Isabelle Huys, Jean-Paul Pirnay, et al.
Frontiers in Medicine|October 27, 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and PracticeRosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, et al.
Digital Health|July 5, 2022
Co-creation with research participants to inform the design of electronic informed consentEvelien De Sutter, David Geerts, Pascal Borry, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 2, 2021
Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique surveyEline van Overbeeke, Brett Hauber, Sissel Michelsen, et al.
Cell and Tissue Banking|September 21, 2013
Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systemsJean-Paul Pirnay, Alain Vanderkelen, Daniel De Vos, et al.
Research Involvement and Engagement|April 7, 2023
Patients as research partners in preference studies: learnings from IMI-PREFERMeredith Y Smith, Rosanne Janssens, A Cecilia Jimenez-Moreno, et al.
Frontiers in Medicine|October 14, 2022
Rethinking informed consent in the time of COVID-19: An exploratory surveyEvelien De Sutter, Teodora Lalova-Spinks, Pascal Borry, et al.
BMC Medical Informatics and Decision Making|November 18, 2022
Using provocative design to foster electronic informed consent innovationEvelien De Sutter, Stef Verreydt, Koen Yskout, et al.
Pageof 21